Cargando…

Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases

A 45-year-old male developed a second set of pulmonary metastases 5 years after surgery for extraskeletal mucinous chondrosarcoma of the left shoulder. He already underwent a lobectomy and two segmentectomies for a first set of pulmonary metastases 2 years ago. The closely grouped three nodules with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Ryuji, Sugawara, Jun, Yamaguchi, Satoshi, Kakuhara, Hisao, Kikuchi, Koyo, Ariga, Hisanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709054/
https://www.ncbi.nlm.nih.gov/pubmed/33299576
http://dx.doi.org/10.1259/bjrcr.20190121
_version_ 1783617670526009344
author Nakamura, Ryuji
Sugawara, Jun
Yamaguchi, Satoshi
Kakuhara, Hisao
Kikuchi, Koyo
Ariga, Hisanori
author_facet Nakamura, Ryuji
Sugawara, Jun
Yamaguchi, Satoshi
Kakuhara, Hisao
Kikuchi, Koyo
Ariga, Hisanori
author_sort Nakamura, Ryuji
collection PubMed
description A 45-year-old male developed a second set of pulmonary metastases 5 years after surgery for extraskeletal mucinous chondrosarcoma of the left shoulder. He already underwent a lobectomy and two segmentectomies for a first set of pulmonary metastases 2 years ago. The closely grouped three nodules within the left lower lung formed a planning target volume (PTV) for stereotactic body radiotherapy (SBRT) with a single isocentre, which was focused on the centre of the largest nodule (the simultaneous plan). Dose-volume histogram analysis confirmed that the plan was superior to an alternative plan, in which SBRT plans would have been produced for each individual tumour (the individual plan). The mean, maximum and minimum PTV doses were 54.0, 57.5 and 47.3 Gy, respectively, in the simultaneous plan, and 65.6, 87.2 and 52.3 Gy, respectively, in the individual plan. The homogeneity index, conformity index, and the maximum dose delivered to the surrounding healthy lung were 1.21, 0.71, and 37.7 Gy, respectively, in the simultaneous plan and 1.66, 4.44, and 46.2 Gy, respectively, in the individual plan. The patient developed Grade two pneumonitis, but remained healthy until 4 years after the SBRT. When multiple closely grouped metastases are treated using SBRT, the use of a single isocentre should be considered.
format Online
Article
Text
id pubmed-7709054
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Institute of Radiology.
record_format MEDLINE/PubMed
spelling pubmed-77090542020-12-08 Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases Nakamura, Ryuji Sugawara, Jun Yamaguchi, Satoshi Kakuhara, Hisao Kikuchi, Koyo Ariga, Hisanori BJR Case Rep Case Report A 45-year-old male developed a second set of pulmonary metastases 5 years after surgery for extraskeletal mucinous chondrosarcoma of the left shoulder. He already underwent a lobectomy and two segmentectomies for a first set of pulmonary metastases 2 years ago. The closely grouped three nodules within the left lower lung formed a planning target volume (PTV) for stereotactic body radiotherapy (SBRT) with a single isocentre, which was focused on the centre of the largest nodule (the simultaneous plan). Dose-volume histogram analysis confirmed that the plan was superior to an alternative plan, in which SBRT plans would have been produced for each individual tumour (the individual plan). The mean, maximum and minimum PTV doses were 54.0, 57.5 and 47.3 Gy, respectively, in the simultaneous plan, and 65.6, 87.2 and 52.3 Gy, respectively, in the individual plan. The homogeneity index, conformity index, and the maximum dose delivered to the surrounding healthy lung were 1.21, 0.71, and 37.7 Gy, respectively, in the simultaneous plan and 1.66, 4.44, and 46.2 Gy, respectively, in the individual plan. The patient developed Grade two pneumonitis, but remained healthy until 4 years after the SBRT. When multiple closely grouped metastases are treated using SBRT, the use of a single isocentre should be considered. The British Institute of Radiology. 2020-06-18 /pmc/articles/PMC7709054/ /pubmed/33299576 http://dx.doi.org/10.1259/bjrcr.20190121 Text en © 2020 The Authors. Published by the British Institute of Radiology This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Nakamura, Ryuji
Sugawara, Jun
Yamaguchi, Satoshi
Kakuhara, Hisao
Kikuchi, Koyo
Ariga, Hisanori
Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title_full Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title_fullStr Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title_full_unstemmed Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title_short Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
title_sort stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709054/
https://www.ncbi.nlm.nih.gov/pubmed/33299576
http://dx.doi.org/10.1259/bjrcr.20190121
work_keys_str_mv AT nakamuraryuji stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases
AT sugawarajun stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases
AT yamaguchisatoshi stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases
AT kakuharahisao stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases
AT kikuchikoyo stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases
AT arigahisanori stereotacticbodyradiotherapywithasingleisocentreformultiplepulmonarymetastases